Early detection saves lives. This fundamental principle of oncology becomes especially critical when dealing with rare cancers—diseases that often remain hidden until advanced stages. Artificial intelligence is now revolutionizing how medical professionals identify these elusive malignancies, offering new hope for patients worldwide.
Rare cancers account for approximately 22% of all cancer diagnoses, yet they receive significantly less research attention than common cancers. Many of these conditions present subtle symptoms that can be easily misinterpreted or overlooked entirely. The integration of AI technology into diagnostic processes is changing this landscape, providing unprecedented accuracy in detecting cancers that traditionally escape early identification.
